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1Preface
It is the purpose of this thesis to describe the
methods used in the advertising and selling of pharmaceutical
products. It is not expected that this thesis will plot any
perfect or sure method for the allocation of the advertising
budget so as to assure a successful sales campaign for phar-
maceutical products. There are known facts and workable
ideas which may be applied anywhere and when properly used
will serve as guides and will tend to reduce many of the
wastes and reduce many of the risks prevalent in the adver-
tising and selling of pharmaceutical products.
I wish to express my thanks to the following people
who have been instrumental in helping me to compile the
necessary material for the writing of this thesis:
Mr. 1. W. Frohlich of L. W. Frohlich & Co., Inc., New York, N. Y.
Mr. Paul IClemtner of Paul Klemtner & Co., Inc., Newark, N. J.
Mr. Harold J. O’Neill of Fisher-Stevens service, Inc,,
New York, N. Y.
Mr. Charles I. Baldwin of the Medical Society of the State of
New York, New York, N. Y.
Kiss Dorothy Noyes and Mr. A. E. Sproul, Jr. of Noyes and
Sproul, Inc., New York, N. Y.
Arthur M. Sackler, M. D. of ./illiam Douglas McAdams, Inc.,
New York, N. Y.
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2 .
Harvey L. Daiell, M. D. of Lakeside Laboratories, Milwaukee,
Wis.
Mr. Leo E. Bova of Lever Brothers, Cambridge, Mass.,
and those people to whom I have given credit at the begin-
ning of each chapter, for without their help and cooperation
this thesis would not have been possible.
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I . A Thumbnail Sketch of the
History of Advertising
For the material in this chapter
I am deeply indebted to Printers' Ink
for the use of the material appearing
in the publication "Printers' Ink,
1888 -1938 ".

4 .
A Thumbnail Sketch of the History of Advertising
During the period of the 1880's the principal ad-
vertisers were St. Jacob's Oil, Castoria, Dr. Pierce's
Remedies, Schenck's Mandrake Pills, Scott's Emulsion, Ivory
Soap, Sapolio, Royal Baking Powder, and Pear's Soap. The
largest single advertiser of the period was Charles A.
Voegeler & Company (St. Jacob's) which is believed to have
spent $500,000.00 in 1881.
The total number of advertisers spending as much
as $100,000.00 in any one single year was probably less than
a dozen. And most of these were patent medicine companies.
This latter industry was, of course, the leader in the use
of advertising ('retailer' excepted) in the 1880's, as it was
in the 1870' s.
Many business men of this period considered the
idea of using advertising unthinkable. They believed and
regarded it as somewhat of a "confession of weakness". What
is more important few of them thought it necessary, and the
publisher offered little encouragement or support. It was
not long since it had been considered derogatory to a pub-
lication to contain advertising. Many publishers would al-
low advertisements to run after the contract for the space
had expired, thus demonstrating to the advertiser that he
was paying for space which the publisher himself considered
to be of no value.
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5Another thing was that the advertiser had to pur-
chase his experience first hand. There was no way of having
access to the experience of others, except in such informa-
tion as the advertising agent might supply on the subjects
of rates and circulation.
And so, while the art of the advertiser was per-
ceptibly entering its formative stage in the 1880's, the
real strides were yet to come. Most of the business news
consisted of word of mouth and continued to be transmitted
by the same medium unless the subject was a craze or a fad
taken up and publicized by the newspapers.
As far as the use of advertisements were con-
cerned, the "my business is different" attitude did not
yield so easily, however, in the transference of the adver-
tising idea from one industry to another. It was not until
the twentieth century had fairly begun that the manufacturers
as a whole were inclined to listen to the broad proposition
that advertising as such was a potentially profitable sales
tool
.
There were two reasons. The first was that the
leading established firms which had the capital and the dis-
tribution to make modern marketing methods possible did not
think that advertising was necessary. "We are already at
the head of the trade", ran the argument, "so what have we
to gain by advertising?"
.,
..
1 ", •
, ; .
'
.
: : i ' - •;
r
<
.
;
: -
:
. .
£ - : . • ' •
. -
^
.
6During the 1890’s, and "before, the general adver-
tising agents and their compatriots their special agents
didn’t, for the most part, have the organization or the
"basic grasp to sell the advertising idea on a fully con-
structive "basis. They created much new business to be sure,
but they followed the lines of least resistance in going to
firms in those industries where there was already an adver-
tising precedent. And besides, they had their hands fairly
full dealing with the expanding activities of the volunteers
who were joining the advertising ranks.
Factors apparent in an examination of the lines of
business where the idea of the continued systematic use of
advertising took hold will show the reasons quite plainly.
The patent medicine industry - (a) Specialty item which was
bought for what it did or was alleged to do rather than for
what it was made of and was trade marked or carried a trade
name on which to build repeat sales; (b) Consumer respon-
siveness for these items was more widespread; (It must be
remembered that doctors and responsible druggists were prac-
tically unknown except in a few large cities; most of the
family medical supplies were bought at the village general
store) (c) The cost of production of these many medical
marvels was so small as compared to the selling price that
the proprietors could afford to take the chances no other
businesses could. One manufacturer, for example, sold his
»t
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product at six bottles for $5.00, and it was fully 90$ clear
profit, the cork and the bottle costing more than the con-
tents .
The history of advertising as an economic force
goes back only some sixty or seventy years. Many people now
living can remember a time when there was little or no ad-
vertising when it took years instead of days for a
useful new product to become known when many of the
conveniences of modern life were so rare and expensive that
they could only be enjoyed by the well-to-do.
Many people can remember, too, when advertising as
a business was looked upon with suspicion. The products
promoted were, in many instances, of dubious worth. Trade
practices governing the preparation and placing of advertis-
ing suggested a racket rather than a profession.
There has been a remarkable development in the ad-
vertising business, over the past half-century, and a con-
stant rise in standards. The main news in the medicine field
was the arrival of Omega Oil, and the methods used for intro-
ducing that product created a stir throughout the advertising
business. Not one druggist had Omega Oil in stock when the
advertising commenced in 1898. The company hadn’t a salesman
to its name. It had determined to sell through jobbers only.
This was the first clear cut case where advertising had been
used to establish a market for a product on a sheer consumer
demand
.
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8 .
The campaign featured an illustration that came to
be widely talked of. It was a picture of a slightly foolish
looking hoy with a flock of geese. The copy said: "Don’t he
a goose. Use Omega Oil." Everywhere people wondered just
what this was all about. The fact was that the picture had
no meaning; it was just a notion of a way to attract atten-
tion. Sales came in hig volume and Omega Oil was a sensation,
though it later appeared that the first several years were
costly from a profit standpoint. Ultimately the business
turned the corner, hut as was later confessed by Bert M.
Moses, who was in charge of the advertising, there had been
some uneasy months.
The apparent initial success of the company was in a
way an unfortunate influence on business generally. There
were few in the trade who liked to believe that advertising to
the consumer was the complete answer to any market proulem,
that the dealer and the channels of irp^e could be ignored.
All you had to do was get the consumer to ask for the product
and the trade was at your mercy. The Omega Oil case seemed to
support this position, and the following facts did not catch up
with the original impression of the company’s success. At any
rate the entrancing theory of forcing distribution died a slow
death and in the throes caused the waste of many an adver-
tising dollar in the years that were to come.
Advertisements of fake and worthless products were
beyond all question one of the greatest deterrents to the
-.
• •
t
•
•
.
.
.
X
.
.
<
.
'
,
9development of advertising. Conversely, the growth of the
business tool closely paralleled the routing of the fraud ad-
vertisers out of the advertising columns.
More keenly aware than ever of the value of reader
confidence and of the hesitancy of the manufacturer of honest
products to associate with the fakers, publishers greatly in-
creased their efforts in purging their pages of the copy of
spurious medicine makers, the "lost manhood" preparations,
the stock schemes, the mail order cadgers and other question-
able products and services. Not only were these offerings
but the advertisers of them were the chief offenders in
bombastic statement and sensationalism in copy and illustra-
tion. Their advertising ethics closely corresponded with
their regard for the meritorious quality of their products.
By 1905 almost every publication of real rank main-
tained rigid standards against admission of the fraudulent
product to the columns. Quite a few refused all medicine
copy.
Meanwhile one publication had taken the offensive
against the advertiser of spurious medicines. The Ladies'
Home Journal, in 1904, touched off the opening attack on
fake remedies. First the actual contents of many of the al-
leged medicines was exposed and the fact that some of them
embodied high quantities of alcohol, others deleterious drugs
such as opium and morphine, was brought into public view.
Then their methods of doing business was taken up. Edward Bok,
,
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10 .
who directed the campaign, enlisted the services of a young
New York lawyer named Mark Sullivan, who revealed, among other
things, methods of getting testimonials from Congressmen and
the practice of selling letters from customers to other firms.
In 1905 Collier’s Weekly joined the fray with a per-
haps even livelier series of exposures. Robert J. Collier,
with Bok's permission, employed the services of Sullivan, then
enrolled Samuel Hopkins Adams in the crusade. The result was
a hard-hitting, unremitting campaign which gave further circu-
lation to the public knowledge of the prevalent evils. The
articles named names and took specific products and analyzed
their ingredients with relationship to the benefits claimed
for the remedies including complete cure of constipation,
cancer, yellow fever and meningitis.
Other periodicals and newspapers joined the cause.
Closing of advertising pages to the fakes proceeded at greater
rate than ever before. And, most important of all, the public
was so well awakened to the frauds practiced upon it that
these activities may be said to have contributed in a major
way to the passage in 1906 of the National Food and Drug Act.
The new law made it a misdemeanor to make or sell
adulterated or misbranded foods, drugs, medicines or liquors
and also prohibited the receipt of such goods. (Prohibition
of false or fraudalent claims on labels did not come until
the passage of the Sherly Amendment some years later.) Dr.
Harvey Wiley, Chief of the Bureau of Chemistry, had a good
--2
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11 .
deal to do with its inception and passage and he set about
energetically to assure its effective enforcement.
A move to control food and drugs advertising ap-
peared in 1933 with the introduction into Congress of the
Tugwell Bill, a proposed revision of the pure food and drug
statute. In its original form the bill, unobjectionable in
its motive, was a tyrannical expression of fanatical zeal.
Under the guiding hand of the late Senator Royal S. Copeland
the bill was modified into sensible channels and finally an
instrument was evolved which on the whole was acceptable to
decent business and which embodied desirable protection both
for consumer and advertiser.
The Copeland Bill, as it became known, was in the
Congressional hopper for nearly five years. The outcome was
the passage in the spring of 1938 of the Wheeler-Lea Act,
which gave the Trade Commission authority over false and mis-
leading advertising of any commodity, with a special section
covering foods, drugs, devices and cosmetics.
Shortly after the Wheeler-Lea passage, the Copeland
Bill was enacted as the Federal Food, Drug and Cosmetic Act.
It expands the regulation of standards of foods and drugs and
brings cosmetics under its jurisdiction, but the advertising
provisions remain with the Trade Commission.
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II Direct Mail
For the material in this chapter I
am indebted to the following men:
Mr. A. Douglass Brewer,
Ciba Pharmaceutical Products, Inc.
Mr. William T. Doyle,
Lakeside Laboratories, Inc.
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Direct Mall
One of the first steps most pharmaceutical houses,
regardless of size, undertake is to set up a direct mail
program. The reasons for this are obvious. The general
principle governing the choice of direct mail versus pub-
lication advertising is the nature of the customers to be
reached. If the customer is known, if his name and address
are available, then experience has shown that direct mail
is more profitable. If the potential buyer is an unknown
member of the general audience, then in most cases he will
have to be selected from this group by publication adver-
tising. The physician is known-his name and address are
readily procurable. It is for this reason that pharmaceuti-
cal and other medical supply houses use large quantities of
direct mail advertising matter. Direct mail is the most ef-
fective, most economical and the most direct method of sales
promotion. Its area of attack, its timing of presentation
and selection of audience without waste circulation is more
easily controlled than for any other media. It is strong
enough to be used as a supplement to personal field repre-
sentatives, journal advertising, house organs, visual educa-
tion and/or other means of sales promotion.
On the surface these statements seem rather bold,
but when consideration is given to the fact that many hun-
dreds of millions of dollars are spent each year in direct
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mail presentation, there would seem to be confirmation of
these statements.
How is a direct mail department started? There are
two ways. The one usually adopted by all the smaller pharma-
ceutical houses and by many of the larger ones is to take ad-
vantage of the services offered by a commercial addressing
and mailing company specializing on physicians' lists. For
example, in New York City there are two-the Pronto Addressing
and Mailing Company and the Fisher-Stevens Company. These
two organizations contact the pharmaceutical manufacturers
and secure their direct mail business. It is rather expen-
sive and cumbersome to set up one's own mailing department
and therefore these two commercial companies do a flourishing
business. The backbone of their mailing list is compiled
from names of physicians secured from the Directory Service
Department of the American Medical Association in Chicago.
Prior to the war this division of the American Medical Asso-
ciation used to publish a directory each year.
The subscribers to it would receive a copy of the
directory; at two-week intervals during the year a mimeo-
graphed supplement listing the new doctors, the changes of
address, transfers, deaths, etc., was sent out so that mail-
ing plates could be corrected and kept up to date. In addi-
tion to this source these commercial companies have access
to the salesmen's reports sent in to their clients' head-
quarters as the changes are forwarded along for information
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18 .
and action. The telephone directory, and city directory are
also valuable aids in securing correct names and addresses.
These names are transcribed onto addressograph plates with
pertinent information regarding the doctor concerned such
as his specialty, his college and hospital connection. It
is then a relatively simple job for the advertising manager
of the pharmaceutical house to have prepared, under his own
supervision or by an agency, various mailing pieces which
are turned over to the commercial addressing and mailing
company for distribution.
The alternate method of handling this problem is
for the advertising manager to purchase and set up all the
addressograph plates keeping them up to date in much the
same manner as is done by the mailing company. Naturally,
this method calls for a substantial investment.
There is no set type of mailing piece or mailing
plan which has been found the perfect solution. By trial
and error each pharmaceutical house settles upon a formula
which has proved most productive in its own experience.
Years ago it was more or less an accepted practice to send
out quite formal, severe announcements or notices in plain
black and white under first class postage. When the first
class rates were advanced to three cents, the majority of
houses abandoned this policy and sent out their mailings
under the privileges of the third class bulk postal rates.
Many surveys have been run over a period of years by
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different organizations, and it is quite surprising to note
that the small difference in reader acceptance between first
and third class mail or between stamp, indicia, or metered
mail is really negligible.
Similar findings are revealed when a study is made
of the envelope. At one time it may seem that a colored en-
velope or one bearing a message, attractively displayed,
meets with less resistance in the physician's office; the
exact opposite may hold true a few months later when a plain
white envelope receives prompt attention.
The average mailing piece produced by the pharma-
ceutical houses of today is a far cry from that used even
ten to fifteen years ago. Realizing that the physician is
first of all a human being and, secondly, a scientist, those
concerned with the preparation of direct mail have fallen in
line with the practices employed by the large advertising
agencies handling general accounts. In brief, it has been
found that colorful, attractive displays of art and copy,
novelty pieces and even cartoons, all have their place in
bringing a message to the physician.
Studies which have been made in large cities as
well as in suburban areas lead one to believe that the aver-
age doctor receives on his desk anywhere from 85 to 90 per
cent of his mail, only a small percentage being intercepted
by the secretary or nurse. The doctor acts exactly like
other people in scanning the morning's mail by quickly
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20 .
opening and discarding certain pieces while laying aside
others for more thorough reading and filing. Known observers
report that the action of the physician in handling his mail
is based first of all on his opinion of the house from which
the mail is sent. That is, he has a certain group of com-
panies in which he has confidence, possibly through constant
use of their products, the soundness of the manufacturer’s
research laboratories, the conservativeness of claims and
presentations, or through his own personal relations with the
company and its representatives in the field.
Another impulse which guides him in his reactions
to the mailing pieces is the timeliness of the subject matter
and its adaptability to his own particular practice. Almost
every doctor is anxious to keep abreast of progress and prac-
tice in medicine and to build up an adequate reference file.
Among the type of mailing pieces which have been found to be
most useful are those containing anatomical charts, abstracts
or reprints of papers from leading universities and clinics,
or a complete discussion of specific diseases and their
treatment
.
The pharmaceutical manufacturer has a great deal of
competition in gaining the doctor’s attention even though he
takes advantage of all these known factors as it has been es-
tablished that from four to six pieces of pharmaceutical
direct mail reach the doctor's desk every day. To this, nat-
urally, must be added the quantity of his own personal mail
and solicitations from other types of business.
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When a company Is small or in a "growing up" proc-
ess, it is usually the practice to limit the mailings to
physicians in those territories where distribution has been
secured and can be adequately watched. If for any reason it
is not practical to send mail to every doctor in these lo-
calities, it is best to concentrate on the key physicians,
the ones who are outstanding because of their institutional
and teaching qualifications or because of their hospital
connections and lucrative practice.
As these small areas become more and more satu-
rated and profitable, the advertising program can be ex-
tended to adjacent counties or new promising areas. It is
much more profitable to cover a specific zone intensely and
consistently than to spread the message over a wide, uncon-
trolled area under an indefinite program.
At the present time the chief problem of every
house is to win the favor of the thousands of physicians
who are returning from duty in the armed services. This
is rather a complicated problem as many of the physicians
themselves have been unable to formulate definite plans
for their own futures. Some are returning for postgraduate
work or refresher courses; others are struggling to find an
office or sharing one with other colleagues and almost all
of them are having a difficult period of readjustment.
Special literature has been prepared by several manufacturers
and is mailed exclusively to this group of prospects in an
&,
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endeavor to help them catch up with medicine as it is prac-
ticed in civilian life.
According to the latest figures 25,000 doctors re-
turned from war-time duty have registered with their local
medical societies which means that their names and addresses
have been recorded by the Directory Service Bureau of the
Medical Association; however, there are still several thou-
sand who have not affiliated themselves with a medical group
and consequently the manufacturer will have to struggle along
with this problem for a considerable period until conditions
become more stable.
So important is direct mail in the manufacturer's
weapons of attack that anywhere from 40 to 75 per cent of
his promotion budget is devoted exclusively to this type of
promotion.
The majority of manufacturers expand their mail
campaign to include hospital staffs, internes, medical
students and prescription pharmacists as it has been proved
that thorough coverage in these allied fields adds to the
effectiveness of the mailings to physicians.
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Ill Detail Men
For the material In this chapter I
am indebted to the following men:
Mr. Clyde Williams,
Whitehall Pharmacal Company.
Mr. Tom Jones,
Paul Klemtner & Company, Inc.
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Detail Men
A. Introduction
Detail men are those men employed by pharmaceuti-
cal manufacturing firms to make personal calls on physi-
cians, hospitals and/or pharmacies within a given territory
to promote the sales of the drug products of the company
through regular and proper channels. According to a sur-
vey made by "Economies of Medical Marketing" in 1941, the
answers to the following questions are indicative of what
a detail man rau3t consider when making a personal call:
Question : All in all, what attribute do you find most wel-
come in detail men?
Consideration of a doctor's time 32#
Knowledge of product 20#
Good personality 13#
Sincerity 10#
Honesty 10#
Ability to speak clearly and understandably 6#
Ability to take "NO" for an answer 3#
Question : What attributes annoy you most?
High pressure salesmanship 24#
Occupying too much time 16#
Lack of knowledge of product 16#
Insult doctor's Intelligence 16#
Misrepresentation 9#
. .
•> !>
c . 3
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Knock other felloVs product 8$
Memorized speech
Lack of sincerity 4#
Success in detailing depends upon the ability of
the individual to convey his knowledge of a preparation to
the physician, pharmacist, or hospital technician with
finesse, tact, and brevity, as well as his ability to
readily evaluate the characteristics of the physician,
pharmacist or technician he is interviewing.
It is very important for the detail man to create
a good impression because through the detail man the impres-
sion of the company is transmitted since the detail man is
representative of the firm he represents. The story the de-
tail man tells must be one that is interesting; he must sell
the merits of his product. Briefly state the claims and the
qualities of the product. The conclusion of the interview
is the part of the interview that must not be overlooked be-
cause the detail man must endeavor to leave the office door
open so that he may return at a future date and again be
received
.
B . Detailing the Physician
When a detail man calls directly on the doctor at
his office, he should remember that the physician's time is
very valuable and the detail man must remember that the
rules of personal selling hold him tighter here than at any
other time or place. He should not allow himself to be
.-
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confused with the doctor’s patients, but he should give his
name and the nature of his business to the nurse or recep-
tionist. If the waiting room appears crowded and the doctor
is busy, it may be to the detail man's advantage to suggest
that he will call back at some other time, perhaps later in
the day. When the detail man does meet the physician he
should not take up the physician's time with unnecessary
trivial talk. He should tell the physician the merits of
his product and state the indications for which the product
may be used, thus leaving the physician with a constructive
thought pattern that he will apply by prescribing the
product. At the time of the interview it is well to provide
the physician with any selling aids that the detail man has
for that purpose. The detail man must always bear in mind
the many conditions in which they are applicable; and by
reciting these applications to the doctor, the detail man
should always be prepared to answer any questions the physi-
cian (or any other person being interviewed) may ask about
all products in his firm's line. The detail man should not
take up anymore of the doctor's time than is absolutely
necessary for him to make an effective and coordinated
presentation. Remember, the doctor's time is valuable.
C . Detailing the Drug Store
The distinction that I make for a drug store is
that even though they do sell drug products the greatest
volume of sales is in the variety store type of merchandise.
V-
|
'
'
-
; j -.j" ; > : .
;
" :
.*
-
-
:
'
-
3
- J
• :
'
•
^ - ;
xx 'i
3,;
'
: J I
.
.
-;j ' : z •• -
.
-
'
-
.
'
•
: - : : - - -
'
-
; : ;; ..
’
.
.3
: :c
•
.
3 -
-
1
‘
;
’ / • 3 ’ -
-
;
• t j
2 - - 3 J -
The doctor has but two methods of applying medica-
tion namely: 1) by dispensing medicine from his own stock,
or 2) by giving the patients a prescription to be filled by
an outside source--the drug store or pharmacy. Medication
dispensed by the physician generally consists of standardized
formulae which are manufactured by various pharmaceutical
concerns and sold to the dispensing physicians in large quan-
tities. Frequently the dispensing physician has formulae of
his own in which he has great faith, and he may have these
made up for his own personal use by a pharmaceutical manu-
facturing firm.
Prescriptions filled by the pharmacy may be pre-
pared from various ingredients manufactured by chemical and
pharmaceutical concerns, but in many instances the proprie-
tory product of various concerns is designated in the
prescription, without change except that the manufacturer’s
label is removed and the pharmacy prescription label, bear-
ing the physician’s name, is substituted for the label that
has been removed. Since the general trend has been toward
the prescribing on the part of the doctor this shows what an
important link the pharmacy and the drug store is for the
detail man.
As I have said, the detail man is the liaison man
between the pharmaceutical manufacturing firm and the
doctor, likewise he can be considered as the liaison man
between the pharmaceutical manufacturing firm and the
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pharmacy and the local drug store. The detail man must be
considered as a liaison man because many times the doctor
must rely on the pharmacist for information about products
not only as to their use and application but also as to
relative merits of similar products.
The detail man should make it possible and easy for
the pharmacist to have a complete file of all the products
stocked by the drug store. By getting the cooperation of
the better class of drug stores, the detail man has another
salesman for his products in the territory of the local
doctor
.
D. Detailing the Ethical Pharmacy
I made a distinction as to what I considered a
drug store--I also will define an ethical pharmacy. An
ethical pharmacy does its greatest volume of business in
the sales and compounding of drug products and wishes to
continue doing this. The detail man may find it advantage-
ous to stop at these ethical pharmacies because they may
wish to expand their volume of business.
It will be of mutual benefit if the detail man
who calls on the ethical pharmacy has some concrete and
definite ideas as to how the volume of prescription busi-
ness may be increased. It has been suggested. In Tom Jones'
book, "Detailing the Physician"; that one method of doing
this would be to use the window display space of the
pharmacy to tell the story of ethical pharmacy. Also, It
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would be good procedure if the pharmacy would use its shelf
space for the advantageous display of its ethical products.
Make it apparent to the customers of the pharmacy that the
primary interest is in pharmaceutical and drug dispensing
business and is not interested in variety store trade or
merchandise
.
Impress the pharmacist with the importance of
calling upon the physicians at regular and frequent inter-
vals. Everyone, doctors included, likes to know what the
people he is expected to do business with look like. The
pharmacist must be careful not to make the mistake of try-
ing to tell the doctor what to prescribe because the phar-
macist's only reward will probably be diminishing prescrip-
tion business. One of the best reasons for making personal
calls on the physician is stated by Dr. Frank B. Kirby of
Abbott Laboratories who stated that every year the average
physician writes prescriptions worth $1,159.20. These facts
are pointers as to why personal calls on the part of the
pharmacist should not be overlooked and should reap a most
generous reward. 1
Direct mail can also be used advantageously by the
pharmacy, either doing the complete job itself or by having
a tie-in with the manufacturer whereby the pharmaceutical
manufacturing firm sends the mailing pieces under letterheads
1
-Detailing the Physician-Tom Jones, p. 156
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of the pharmacy. It is to the benefit of the detail man to
advise the pharmacist of this and direct his attention to the
possibilities of enlisting the aid of other pharmaceutical
manufacturing firms.
One important thing the detail man must remember in
dealing with the retail outlets—don’t overstock them. Stock
that does not turnover loses strength and the packages and
containers may get soiled or broken. Products that are held
in this manner hurt the manufacturer of the product not only
for that one product but for the complete line of products
that are manufactured. The initial order is not the big thing
but that orders keep coming in because this is the indicator
of satisfaction not only on the part of the pharmacy but also
on the part of the consumer on whom the ultimate sales depend.
E. Detailing the Hospital and the Hospital Technicians
Hospitals offer another outlet for the detail man's
efforts in his territory. Hospitals as individual units are
the largest known users of pharmaceutical products and in-
gredients. The greater acceptance a pharmaceutical firm can
get in the hospitals, the greater chance that firm has for
growth. This statement is qualified by the preceding state-
ment and also by the fact that the interns of today are the
practicing physicians of tomorrow. The drug products that
these interns become familiar with during their internship
they will use when they go into practice. The intern may also
be able to give the detail man an entry into the hospital
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routine. This may be accomplished by the in-tern suggesting
the use of the pharmaceutical product to the members of the
hospital staff or by suggestion to the attending physician
on a case where the intern may be working. If the product
lives up to the claims made for it, the detail man will have
gained an important acceptance which should be mutually
beneficial to both the user and the pharmaceutical manu-
facturer.
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Quick Distribution Methods
Manufacturers with a small force of detail men can
establish distribution quickly and effectively by using the
following method:
Assemble a group to work in a given geographical
area. The composition of the group would follow the pattern as
under:
1, One sales manager or sales supervisor
2, One medical director, chemist, or technician
from manufacturing department
3, Sufficient detail men to cover the selected
physicians in the territory within the time allotted to the
project.
The plan would be operated as follows:
1, The sales manager or sales supervisor has a
map of the city and spots his men in the sections he wishes
them to detail physicians.
2. The sales manager or sales supervisor calls on
the wholesale and jobbing buyers - and sees that their telephone
order takers are informed that the product to be detailed is
in stock.
3, The medical director or other technician con-
tacts hospital-clinics and universities to explore possi-
bilities for clinical research.
4. The detail men contact professional pharma-
cies in the mornings and detail the selected list of physi-
cians as early as possible during each day.
*r
.
.
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During tne dayb work, tn© wholesalers* buyers, the
professional pharmacists (and their detail men) have been
invited to have dinner at the hotel in the evening with the
group that is working in the area. The advantages of these
meetings are apparent:
1. The wholesalers, jobbers and professional phar-
macists are impressed with the organized plan and tne ef-
fectiveness of the work being done. All present usually
participate in discussions and ask questions which are
answered by the manufacturers* sales manager and technician.
Hence everyone becomes better informed. Often the original
plan can be revamped for greater effectiveness tnrough thoughts
brought out during these discussions. When tne project is com-
pleted a detail man or men are left behind to follow up. Direct
mailings to physicians are scheduled on a timely basis and later
the working group may return to high spot the area.
2. Adequate distribution and immediate sales are
achieved - a program of this type has been known to pay for
itself within eight months or a year.
3. Detail men working within the group, find that
they learn more about the product they are detailing - find
that they can make more calls - than they usually make in
tneir established territory - hence return to tneir regular
territory and work with renewed vigor.
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A Direct Mall Metnod To Obtain Distribution
Samples are sent to selected physicians (when possible)
enclosing a business reply card asking the physician for the
name of the pharmacy where he would like the particular product
stocked. If the card is not returned, a follow up letter request-
ing the same information should be sent.
When tne name of the pharmacy is received, a retail
package should be forwarded to the pharmacy indicated, together
with a letter advising the pharmacist that a physician in his
neighborhood suggested that the pharmacist stock the product.
The pharmacist will usually tell the physician that he has the
product available.
Direct mail promotion to professional pharmacies,
(there are about lu,uuu in this particular category) followed
up with a retail package as a sample and supplemented by direct
mail to the physicians in the areas where the professional
pharmacies are located, is often effective. Distribution is
accomplished and sales result rather quickly from this
method. The average run of drug stores usually turn to the
professional pharmacists for prescription products which
these drug stores do not carry - hence the actual availability
of a product is greater than appears on the surface. This
method achieves an unusual degree of acceptance by the physi-
cian, because of the prestige accorded to the professional
pharmacist by the medical profession.
..
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For the following Inserts
I am deeply indebted to
Mr. Albert J. Weisbrodt, Advertising Manager,
Burroughs 'Wellcome & Co. (U.S.A.) Inc.
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Detailing is an art acquired by some people almost over-night and then again by others
not even in a lifetime. In a sense, detailing is selling in white tie and tails—conser-
vative, dignified, prudent. It is a gentlemanly profession with "servicemanshij/’ the
keynote. Products are presented to the medical profession in terms of relief of pain,
alleviation of suffering, normalizing of human existence. Professional preference and
specification are the fruits of skillful detailing in which the advantages to the physician
of using the product are given special prominence. The quiet efficiency, ingenuity
and resourcefulness of the successful medical representative are the chevrons of one
who has mastered "the art of detailing.”
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DO'S AND DON'TS WHEN DETAILING
„..let your pharmaceutical training
supplement the doctor's therapeutic
knowledge
.
. . .plan your presentation on each prod-
uct, know exactly what you are going to
say and how you are going to say it.
...admit you don't know when the doctor
asks a question that goes “beyond your
information on the product - refer the
question to the Medical Department for
a reply.
...coordinate your detailing with the
theme used in current medical adver-
tisements and direct mail literature.
...present the product to the physician
in terms of "what it will do" and "how
it will do it better" than existing
preparations
.
...demonstrate the product wherever
possible getting the physician to take
part in your demonstration.
...give your detail authority by fre-
quent quotations from published papers .
. . .use simple, concise, clear-cut state-
ments . Avoid awkward medical termin-
ology if it is not in common use.
...learn the facts about your product
but avoid stereotyped, memorized presen-
tations .
...know how your products are superior
to other preparations but avoid the use
of competitive brand names.
...make it a point to see all "key"
physicians even though you have to
spend a little more time to see such
busy men.
...present the doctor with a specimen
until you are sure he is interested in
the product and will give it a fair
trial
.
...fumble for literature or products
in your bag thereby interrupting the
smoothness of your detail.
...detail products to the physician
that are not in your Detailing-Selling
Campaign except in rare instances.
...call the physician "Doc"; know the
doctor's full name, interests, back-
ground and affiliations before you
enter his office.
...push the product too soon in your
detail; first establish the need for
the product.
...let the interview get too far off
the main topic - be diplomatic in mak-
ing a transition back to the subject
of your detail.
...spend too much time with any one
physician and run the risk of overstay-
ing your welcome.
...adopt a viewpoint that is in direct
opposition to the physician' s viewpoint.
Avoid arguments. Cultivate the "Yes,
but ..." technic
.
...do all the talking yourself. En-
deavor to engage the physician in con-
versation by asking leading questions.
What the physician says are signposts
to guide you in your detailing.
...show by yair attitude that you feel
subservient to the physician nor that
you feel superior to him in your knowl-
edge of the subject matter discussed.
5
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Even though the principles involved are as old as time itself the art of selling the retail
[pharmacist is still without /parallel . for here is a man who has blended high professional
standing with modern business techniques. Fundamentally he is interested in seller
benefits' . namely, the advantages he will derive from stocking your merchandise. I liese
seller benefits' are usually described in terms of ( 1 ) wide profit margins. (2) rapid
turnover arising from consumer demand and/or professional specification and (3)
certain service <pr [prestige features that will, in themselves, ultimately reflect in in-
creased business. These appeals t<p buy your goods have been worn thin by constant
repetition, but they are still basic. Selling becomes an art when these buying motives
are stimulated by new and fresh presentations. Learn to use new words and obi words
new ways.

...know and cultivate the friendship
of the pharmacist as well as all the
other clerks in the store.
...provide the druggist with helpful
selling information to increase his
turnover
.
. . .give suggestions on counter or win-
dow displays.
...sell products on the basis of what
they will do for the druggist rather
than on friendship.
...give information on the products you
sell that the druggist can, in turn,
relay to his customers.
. . .offer suggestions on how the druggist
can increase his prescription business.
...compliment the druggist on any un-
usual displays or merchandising ideas
he may be using.
...cooperate with the druggist in help-
ing him to move any slow stock.
...keep the druggist fully informed on
what is being done to help him sell
B.W. & Co. products.
...leave the pharmacist literature and
sufficient information on all important
products so that he will be in a posi-
tion to discuss these products with his
neighborhood physicians.
...encourage the pharmacist to make
counter and window displays of our
counter-selling items . Seek his cooper-
ation in using our display materials.
...become so friendly with the pharma-
cist that it is hard to persuade him
tobe serious and to hold his attention.
...let the pharmacist feel that this
is just a routine call; always try to
have something of particular interest
to present to him.
...smoke in the drug store unless you
know the pharmacist doesn't mind and
then don't drop cigarette butts on the
floor
.
. . . overs toe k the druggist when he leaves
ordering to your judgement.
...fail to cooperate with your pharma-
cist in detailing important neighborhood
physicians. Many important " leads " can
be secured through him.
...fail to make sure that you have
adequate drug store distribution of
items being detailed to the medical
profession
.
... forget to keep the druggist informed
on all current price and package changes .
...overlook the importance of increas-
ing your distribution of various prod-
ucts. Try to get 100% distribution of
B.W. & Co. items - at least in all key
stores
.
. . .exaggerate potential sales . Develop
the confidence of the druggist through
conservative statements.
...forget that your responsibility to
the druggist ends only after the prod-
uct is in the consumer's hands.
17
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Selling the hospital calls for all the skill a representative has developed in his entire
detailing and selling career. The hospital is a cornplex organization ivith a professional
staff of physicians, surgeons, internes, nurses, dietitians, pharmacists and others who must
he favorably influenced before a product finds its way into routine hospital use. Prod-
ucts are presented to the hospital staff in terms of user benefits ', i.e., what the product
will do for the patient and how it will do it better than similar competitive products.
Those qualities or characteristics are featured that competing products do not have or
do not claim—or at least do not use to the best advantage. These are commonly re-
ferred to as ‘product preference features" . Heal artistry is at work alien a product with
no apparent therapeutic or economic advantages over competing preparations achieves
hosfatal preference.

38
\
DO’S AND DON’TS WHEN SELLING THE HOSPITAL
. . .detail hospital physicians, internes,
nurses:, dietitians:, pharmacists and
others when calling on the hospital.
...advise staff physicians and others
when a product is available in the
hospital
.
...leave literature on products with
all physicians, internes, dietitians,
nurses and others so complete informa-
tion is available to them to refresh
their memories.
...keep hospital pharmacists posted on
all products being actively promoted,
price and packing changes, etc.
...place on floor desks, etc. descrip-
tive blotters, featuring products
stocked
.
...cultivate the assistant pharmacist
as well as the chief. He may head that
department some day.
...go after large bulk sales. Big hosp-
pitals are accustomed to buying tre-
mendous quantities and always take ad-
vantage of bulk prices.
. . .be proud of yourself, your work and
your company. Conduct yourself with
dignity and deal with all in a fair and
straightforward manner.
...keep an accurate record of all B.W.
& Co. products stocked in the hospital.
Be sure to get the repeat business on
these items and place new items at
every opportunity.
...make your hospital calls regularly
and on certain days so the pharmacist
will know when to expect you.
...overlook the importance of the out-
patient clinics:, baby clinics:, etc.
associated with the hospital.
...depend on price alone to get hospi-
tal business. Point out the superior-
ities of the product so the pharmacist
will readily appreciate that it is to
his and the hospital's advantage to
stock the product.
...forget selling and stocking is only
part of the job. Keep the product mov-
ing.
... forget the nurses ' training schools.
See the instructors and give them ap-
propriate literature in quantities
adequate for their classes.
. .
.overstay your welcome with the
pharmacist, superintendent, dietitian,
etc. Plan your talk, say it and then
leave
.
..."buttonhole" doctors in the staff-
room, corridors or wards unless they
indicate in some manner that they are
receptive and want to talk to you.
...wander around the corridors of a
hospital on the chance that you may be
able to get in a detail. Know whom you
want to see and announce yourself in a
businesslike manner at the desk.
...forget to obey the rules of the
hospital with regard to visiting cer-
tain wards. If permission is required
to visit the pediatric, obstetrical or
other floors be sure to get it.
...fail to keep your interne and resi-
dent lists up to date - the pharmacist,
superintendent, medical director, and
the various department heads will be
of great help to you in this matter.
36
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IV. Medical Journals
For the material in this chapter I
am indebted to the following men:
Mr. George H. Doyle,
Modern Medicine Publications.
Mr. William Chapman,
Medical Economics, Inc.
Mr. Gordon Marshall,
Medical Society of the State of New York

Medical Journals
A. Introduction
Medical journals which reach the medical profession
number over 400. These journals vary in size, coverage, edi-
torial content, and type of physician they reach. Approxi-
mately 125 of these medical journals are listed in Standard
Rate and Data Service. Standard Rate and Data Service is an
authoritative buying guide, generally accepted and used by
agency Media Departments and Advertising Managers. Profes-
sional medical journals are publications devoted primarily
to the interests of this special professional group. The
circulation of medical journals is always predominantly
restricted to this specific group or class.
Medical journals are designed to appeal specifically
to the medical market. They reach and influence this market
through editorial comment, technical articles, news items,
and the advertising carried. Those with products or services
to sell such a market can reach a large proportion of the
prospects and influencing factors through medical journals in
three ways:
1. By using paid advertising space,
2. By editorial publicity,
3. By using publication mailing lists for direct mail
advertising and sales promotion material.
Periodicals circulating in the medical field have
many characteristics which are peculiar to themselves. Some
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of the periodicals or journals are sponsored as official organs
of medical associations. Others are sponsored by private in-
dividuals as a profit making project. Some have subscription
lists, others are given away, while still others are a com-
bination of both free and paid circulation.
Some journals cover the profession nationally.
Others cover segments of the profession by regions, states,
counties, and smaller localities.
Editorially, some journals cover medicine in an
over-all manner. Others cover only specific categories of
medical specialties; and in one instance, a medical journal
does not carry any medical text, but approaches the profes-
sion with reference to the economic and business viewpoints
of the medical profession.
B. Association Journals
Association journals are those journals which are
the official organs of the various medical associations. The
journals within this classification vary in editorial text,
circulation, and type of advertising carried according to the
views of the sponsoring group.
The Journal of the American Medical Association is
the official organ of the American Medical Association and
covers the field of medicine editorially in an over-all
fashion. It carries original articles on new developments
in the medical field. It also has an abstract section which
abstracts noteworthy articles from other journals. Members
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of the American Medical Association automatically become sub-
scribers to the Journal of the American Medical Association.
Before any medical, pharmaceutical, or food product
can be advertised in the Journal of the American Medical As-
sociation it must first be approved by one of the councils
according to the category into which it falls. Surgical
equipment must first be approved by the Council on Physical
Therapy, pharmaceutical products must be approved by the
Council on Pharmacy and Chemistry, and food products must be
approved by the Council on Foods.
To secure the approval of the Council may take a
great deal of time and the time lag may be a factor of great
importance to the manufacturer. Even if the time lag is not
important there is always the possibility that the product
may not be approved by the Council.
If the product to be advertised receives the ap-
proval of the Council, many manufacturers believe that a de-
gree of prestige is gained thereby. Just what "degree of
prestige" is actually attained is difficult to determine,
since the manufacturers individually do not agree as to the
relative value of this designation. In any event approval
by the Council cannot be construed as automatic acceptance
by the medical profession as a whole. At best it only in-
dicates that a competent group after investigation have
found that the product has met a prescribed standard and
therefore the membership is informed accordingly.
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The paid circulation of the Journal of the American
Medical Association as indicated in the October issue of
Standard Rate and Data Service was 111,409. This circulation
was taken from the sworn statement of the Association dated
12/31/45. A sworn statement of circulation is determined by
an audit of the subscription lists which in turn is sworn to
before a notary public who in turn affixes his seal.
C . Mass Coverage Journals
Many of these journals are members of the C. C. A.
(Controlled Circulation Audit) which means that the circula-
tion is controlled and subject to audit at the end of each
six month period. C. C. A. statements are generally accepted
as a factual statement of a given journal's circulation.
The three largest C. C. A. Publications in the
Medical Field are: Modern Medicine, Medical Economics and
Current Medical Digest all of which are private ventures and
as such they do not enjoy any official status by a sponsoring
association.
Modern Medicine is primarilly an abstract journal.
Emphasis is placed on treatment and diagnosis. About 90$ of
its text content is abstract material taken from journals of
original issue, covering the new and practical developments
in every specialty of medical practice. Every month a
recognized authority takes a given medical subject that en-
joys a wide field of interest and brings the subject up to
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date# These are original articles# During tne alternate
montns a pertinent chapter of a new medical booK is repro-
duced from galley proof so as to give the medical profes-
sion a preview of tne most interesting section of tne bo ok
before it is offered for sale.
Current Medical Digest is also an abstract book.
Its abstracts are much longer than tnose appearing in Modern
Medicine and fewer in number#
Medical Economics is not an abstract journal# Nor
does it deal at all with treatment or diagnosis# On the con-
trary, it is composed almost entirely of original, staff-
written articles and departments that have to do with financial
problems, office management, insurance, investments, legal
medicine, profiles, medical education, equipment, bookkeeping,
sickness insurance, hospital staff matters, the doctor 1 s office,
personnel, ethics, public and patient relations, specialism,
etc# Hundreds of surveys and interviews are made each year to
gather facts and opinions on which the magazines 1 articles
are based#
D# Specialty Journals
Specialty journals are those journals which cover
only a specific category or specialty of medicine only#
These journals are distributed to specialists in a particu-
lar field and/or to those whose practice leads them into
contact with the problem pertinent to a given specialized
field# These journals may be either official organs of a
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society or special group which it represents or they may be
private ventures#
The specialty journals are very good for those
manufacturers whose product or products have only a limited
application in a wide field. Specialists can be best reached
by the use of these specialty journals because the physicians
to whom the advertisements are directed will spend more time
reading the journal which is covering their particular field
of practice.
If the journal is the official organ of a society
it has a subscription price which is included as a part of
the dues of the society. Typical journals in this category
are Gastro-Enterology, official organ American Gastro-Enterolog-
ical Association; Endocrinology, official organ of the
Association for the study of internal secretions; Military
Surgeon, official organ of the Association of Military Surgeons
of the United States; Surgery, Gynecology and Obstetrics,
official organ of the American College of Surgeons; Radiology,
official organ of the Radiological Society of North America,
Inc.; Archives of Pediatrics, E. B. Treat & Co., Inc., private
venture; Surgery, C. V. Mosby Co., private venture; Urology
and Cutaneous Review, Urology and Cutaneous Press, private
venture
.
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E* Regional Journals
Regional journals, as the name indicates, are those
journals which circulate in a particular region. State
journals maice up the greater part of the regional journals
and are the official organs of the Medical Society of the
state in which they circulate.
Editorially these journals cover medicine in a
general manner and have a limited scope of influence* They
have a very limited circulation but many of the new develop-
ments along certain lines are first found in the contents of
the state and regional journals.
F. House Organs
House organs are those publications sponsored by
pharmaecutical manufacturers, and they are distributed to
the profession at large. These publications are sent by mail
and carry comments on new developments in certain drugs which
are of interest to physicians generally. The house organ
generally carries very little advertising. Invariably such
advertising is confined to products of the sponsoring manu-
facturer. Most house organs are excellently prepared and
attractively printed, and as a promotion feature they are
well received generally by the profession. Among the better
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house organs you will find Abbott's "What's New", Sharpe &
Dohme's "Seminar", Hoffmann-La Roche's "Roche Review", Ciba's
"Symposia.
"
The advantages of using medical journals are:
1. The appeals are directed to a specific and
professional market.
2. If these journals are carefully chosen, the
manufacturer can secure complete coverage of all those
(physicians) who influence the purchase of drug products,
instruments, equipment, etc.
3. Good medical journals are constantly and
widely read by the groups covered as a means of keeping up
with new developments in the practice of medicine.
4. Medical journals have an intimate acquaintance
with the medical market through the physician, the primary
motivating factor in the influencing of sales.
5. The cost of coverage of a specific group is
unusually low per prospect reached.
6. Timeliness of presentation is secured since
closing dates are usually close to publication dates.
7. There is little waste in circulation.
The disadvantages of using medical journals are:
1. Ratio of advertising content to reading matter
may be too high, especially in journals without paid circula-
tion.
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2. Advertisements are generally in the front or
back of the journal and the reader is not led through the
advertising.
3. There is a high degree of duplication of cir-
culation in medical journals.
4. Misrepresentation of both quality and quantity
of circulation is not uncommon among those journals which do
not enjoy C. C. A. membership.
5. Cost per logical prospect reached may be high.
In evaluating the merits of medical journals the
following must be considered:
1. The publisher, his editors and staff and their
qualifications to do the job.
2. The publisher’s field organization, and its
understanding of market problems and the collateral which
are services offered to the advertisers.
3. The publication itself, its character and
quality of editorial text and readership, the ratio of ad-
vertising pages to reading matter.
4. Analysis of circulation - sworn statement or
C. C. A. and the distribution of circulation geographically
and by specialty practice.
5. Rates or costs.
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V. Medical Conventions
For the material in this chapter I
am indebted to the following men:
Mr. Frank Rhatigan,
Davis & Geek, Inc.
Mr. Charles Baldwin,
Medical Society State of New York.
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Medical Conventions
Medical conventions afford the manufacturer of
pharmaceutical products, surgical instruments and equipment
an opportunity to meet the physicians who dispense, use and
prescribe their products.
Medical convention exhibits are of two types.
The first type is the scientific exhibit which is generally
historical in nature. The history depicted is the unusual
in a particular case study or disease. These exhibits are
not nearly so colorful as the technical exhibits which show
and picture the scientific trends in medicine. These
scientific trends have either already been published or at
a later date will be published in one of the medical
j ournals
.
The second type of medical convention exhibit is
the technical exhibit which is designed primarily for pro-
fessional commercial sales. These exhibits may be seen only
at this particular convention.
In order for the manufacturer to garner the fullest
reward for his exhibits it is necessary for him to have an
alert, uptodate man in the booth to meet the doctor. The
best qualified men to meet the doctors who visit the exhibit
booth are those who are qualified to speak on the product in
detail and answer any questions the doctors may want to ask
about the product. Either one of the better detail men or
,.
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the detail supervisor is the type of man that should be in
charge of the company booth. In many instances the inventor
of the products or equipment will be at given booths at con-
ventions. The physicians thereby have the opportunity of
discussing these particular products or equipment with the
men who were responsible for bringing them into being. Many
times the physician learns of different uses for a given
product or equipment from these men, thereby increasing his
knowledge and improving the service he is able to render to
his patients.
It is apparent that the manufacturer should staff
his exhibit booth with thoroughly trained men so that physi-
cians visiting the booth may be impressed by the courtesies
extended and the dissemination of information regarding the
products on exhibition.
The tendency in convention exhibits is toward more
colorful and elaborate backgrounds or back drops. There is
also a very marked tendency to have a definite tie-in between
the backdrop and the manufacturer’s product, trade mark and
slogan.
The selection and procurement of space is the first
step only in any convention exhibit. Selection of space,
however, is important because the flow of traffic is invariably
to the right, therefore exhibits situated at the right of en-
trances and exits are reasonably certain of being exposed to
a greater number of physicians than exhibits located elsewhere
..
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in the convention hall. This tendency of the traffic to veer
to the right is another phenomena that has been observed in
large retail stores, and the fact that display windows at
the right generally receive more attention than windows situ-
ated at the left.
There is a consensus of opinion among a great many
exhibitors that more doctors will attend more conventions in
the post war period. The ex-service physician will want to
catch up thoroughly and quickly on the new methods, new
techniques, new products and new equipment that has appeared
during the war years . There will be a great need for post
graduate work in medicine because of the forced generalization
during the war period. During this time the physician was out
of touch with the many specific aspects of medicine. The war
increased the number of surgeons because of necessity to do
the job required in war service. The stay-at-home and ex-
service physicians will want to do more post graduate work.
Medical conventions embrace all categories of medicine, there-
fore much of this reorientation will take place at the con-
ventions. Furthermore, the post graduate sessions are inten-
sive and are conducted by the best informed men in a given
specialty of medicine.
The post war period will be comparatively more im-
portant to manufacturers than any period before the war.
This will be particularly desirable for those manufacturers
who are developing new ideas, new products, and new methods
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of treatment; and for those companies that developed new
products during the war period but were unable to promote
them because of artificial limitations arising out of war
restrictions
.
With more doctors available to carry the patient
load it is reasonable to assume that the physician will find
it more convenient to attend conventions in the future than
in the past. This being true, conventions offer the manu-
facturer an excellent opportunity to contact many doctors at
conventions. Many physicians living at great distances will
have more time, and with the war restrictions on transporta-
tion eliminated, many who have not attended conventions since
before the war will again resume their attendance.
Medical conventions are generally held annually by
The American Medical Association, state societies and sec-
tional groups. The members of these societies or groups at-
tend these meetings for the following reasons:
1. To attend clinics - to see and hear the latest
advances and developments in medicine discussed. Lectures
are given, new methods and improved techniques are demon-
strated. In this manner the physician is able to keep pace
with the advances made in medical treatment.
2. To maintain Social and Professional Relations -
attendance at these meetings enables the members to broaden
their professional friendships; to make new worth-while
acquaintances. They meet former classmates as well as friends
who have been seen infrequently over a period of time.
.
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These meetings are constructive and beneficial to
the commercial exhibitors as well as to the members of the
society sponsoring the convention. The commercial exhibitors
are invited to purchase space and set up displays. The pro-
ceeds are usually sufficient to defray the expenses of the
convention. In turn, the exhibitors or manufacturers benefit
from the efforts of their representatives at these conven-
tions .
Primary duties of convention representatives are:
1. Registration. It is important to obtain the
names and addresses of all physicians visiting the manu-
facturer's booth. This information is useful in checking
sample lists and for making such additions and corrections as
required in the mailing list.
2. Product presentation. As the members of the
convention register at the manufacturer's booth it is good
practice to give him details on the firm's products, point-
ing out the ways in which the product can be used.
3. Report comments made by any of the members
registering at the booth. Adverse remarks may be of greater
importance to the manufacturer than complimentary remarks.
Report all of them to the firm.
Sampling at conventions depends upon the type of
product that the company manufactures
. There has been a
tendency to stop the giving of samples at conventions be-
cause of an inclination on the part of the physician to
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throw them away when he leaves the hotel because of a lack of
space in which to carry them. The method which is widely
used now is to send the samples and/or literature to the
physicians who have registered at the exhibit booth. This
gives the physician time to read the literature at his leisure,
and he is not encumbered by bulk that cannot readily be car-
ried home from the convention to his office.
Since there are conventions covering all categories
of medicine, the manufacturer must determine which type of
convention is most suitable for the exhibit of his product.
Many products have a limited field of application, therefore
they do not lend themselves to convention promotion except
in instances where the physicians are interested in this
particular type of product. On the other hand foods, or
other products closely allied to the food and drug field,
are of interest to all physicians. Manufacturers of such
products would, in all probability, confine their exhibits
to the larger conventions irrespective of the character of
the sponsoring group.
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VI . Sampling
For the material in this chapter I
am indebted to the following men:
Mr. Frank Rhatigan,
Davis & Geek, Inc.
Mr. Clyde Williams,
Whitehall Pharmacal Company.
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Samp 1 ing
The sampling of pharmaceutical products to the
medical profession may be the principal or the only purpose
of advertising in the professional medical journals. This
may also be the objective of letters and other direct mail-
ings of descriptive literature sent to the physician. Pro-
fessional samples may be sent to the physician without a
request from the physician. This type of sampling is known
as general sampling and involves a great deal of expense and
a great deal of waste. By using a selective mailing list,
sending samples only to those who request the particular
sample, this waste and expense is greatly curtailed, but
the sender loses a percentage of the professional group that
will not take the time or the trouble to write in and re-
quest the sample that they desire. The choice between these
two methods of sample distribution, general sampling and
selected sampling, is one of comparative costs and results.
Another method of distributing samples to the pro-
fessional people is by use of detail men who make personal
calls upon the physicians and other professional groups who
are likely to use or recommend the use of the product to
other people.
Detail men'may also call upon wholesale and retail
distributors of drug products who would be expected to stock
the product and gain distribution for it because of the
" V ' . -
.
j. ol : ©
.
,
.
-
.
.
.
58
demand created through the use of other advertising media as
well as the previous distribution of samples. The distribu-
tion of samples by use of detail men allows the company a
personal presentation to the physician, and thereby, the de-
tail man can answer any questions the doctor may have to ask
about the product. Professional sampling, sampling to the
physician, is only adapted or suitable for certain types of
pharmaceutical products. The type of product best suited
for professional sampling is that product which will show de-
finite results, either positive or negative, with the appli-
cation of a small amount of medication. This type of sample
is of most value because it proves its worth, or proves it-
self of no help, in a short time and does not involve
frequent return trips to the doctor’s office. This saves
the doctor’s time and saves the sampling company the exjjense
of high cost and large quantity samples.
Many pharmaceutical manufac toners supply the phy-
sician and the physician’s office with articles that are
both helpful to the physician and to the patient.
These articles are in the nature of memo pads,
prescription pads, spatulas, office call forms and other
forms for patient distribution and use for diet, baby
feeding, end forms of that nature. Calendars and blotters
are other methods which are frequently used as reminders of
advertising to the physician.
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Professional sampling to the hospitals generally
takes the form of detail men calling upon the hospital staffs
and technicians, acquainting these professional people with
the use and application of the new products and their use
under certain conditions. Another way in which samples are
used in hospitals is in laboratory research experiments. By
using samples in research experiments valuable progress is
made at a nominal cost to the firm providing the samples.
Publicity and free advertising may be provided for the com-
pany supplying the samples by having the name of the company,
which is responsible for making the experiments possible,
publicized in written reports of these experiments. Re-
search, encouraged in this manner, may give an opportunity
for advertising that had hitherto been unavailable. Samples
may be used in clinics for free treatment for persons who
would otherwise be unable to afford it.
By thoroughly acquainting the patient with the pro-
duct and the product name there is a possibility for increas-
ing future sales where follow-up treatment may have to be
purchased from the local pharmacy outlet for the product.
All patients are impressed by professional recommendation on
the part of the physician for the particular pharmaceutical
product which has been used for his treatment.
Some food companies also make a practice of giving
free food or canned milk for new mothers leaving the hos-
pitals with their offspring. This also tends to impress
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upon the patient's mind the professional recommendation on
the part of the attending physician.
Sampling to pharmacies and other retail drug out-
lets is done by detail men for the primary purpose of gaining
product recognition with the product being promoted. This
may be conceived as an extension of the old proverb, that
one picture of a product is worth a thousand words, and one
sample in the hands of the distributor or user is equivalent
in selling power to ten thousand pictures of it. By having
the sample of the product in the hands of the distributor,
along with descriptive literature on the product, there is
an additional available means of informing the customers that
the product is available in the drug store.
The size of the sample to be distributed depends
upon what objective the manufacturer is desirous of reaching.
Combination offers are frequent in non-prescription drug
store sampling, the customer buys a full size package of one
product and gets the sample free. Generally samples to
physicians are of a smaller size which are applicable for
doseage of one patient.
Wholesale and retail pharmaceutical distributors
often express vigorous objection to the distribution of full
size samples because they believe that every package given
away means a lost sale for that product or for a directly
competing product. This objection may be met if the people
to whom the samples are distributed were not users of the
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product or a user of a competing product. Practically, the
profitable use of sampling depends upon whether or not
enough new users are developed to offset the loss in sales
to persons receiving samples who would otherwise have paid
the regular purchase price for the product.
.
62
VII . Conclusions
For the material in these
conclusions I am deeply
indebted to the following
for their help and cooperation:
Mr. Robert A. Hardt
Director of Sales and Advertising
Hoffmann-La Roche, Inc.
Romaine Pierson Publishers, Inc.
New York, New York.
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Conclusions
Within the space of relatively few years the phar-
maceutical industry has grown from what has facetiously been
described as a "pot and pan" operation to one which requires
the best brains and skills in engineering. It has kept
abreast of advances in medicine, science and numerous other
technological improvements. However, there are some who be-
lieve that the marketing methods and techniques of the in-
dustry have not kept pace with those used by some other
industries. There are some who even say that the methods
are as obsolete as the "pots and pans" once used in produc-
tion. If this is true, the reason cannot be that top
management has not shown as much interest in marketing as
it has in production and research. Management in the phar-
maceutical industry has always shown a healthy interest in
marketing and distribution. There was a time when the
selling achievements in the pharmaceutical field were the
envy of many another industry. No firm or industry can ad-
vance on every front simultaneously, and if production and
research received the major emphasis during the war, when
the greatest strides were made, this was as it should have
been.
In the opinion of many of the major executives in
the pharmaceutical industry the point has now been reached
when the present marketing methods should come in for the
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same emphasis and attention as other departments in the
business. Modernize the marketing is, or soon will be, the
program in the front offices of many pharmaceutical manu-
facturers .
It is a certainty that the sales executives of the
pharmaceutical industry will not fear the "microscope" and
will welcome the most searching scrutiny of present methods.
Many are looking forward to the day when they will "get the
nod" and even the "needle". Some have already prepared the
possible site of the hypodermic injection whether it be
deltoid or the inner angle of the upper outer quadrant
largest muscle in the body -- the gluteus maximus -- some-
times evasively referred to as the hip.
Successful promotion in the drug trade, as in
others, depends not upon one method alone but rather upon
the development and use of the most effective combination
of methods. The value of promotion directed to the
medical and allied professions should not be underestimated.
The prescriptions, orders, and recommendations of
the members of the medical and dental professions directly
influence the purchasing habits of our total buying popula-
tion.
A properly planned and coordinated sales and ad-
vertising program directed to the physician, hospital and
pharmacist exerts an influence on the development of volume
of trade branded products at a cost which is surprisingly
...
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low when compared to direct-to-consumer promotion. For ex-
ample, if there is $100,000.00 appropriated for ethical ad-
vertising it will permit the use of good-sized space contin-
uously in practically every national and sectional journal
in the United States
.
General practitioners are the family physicians.
What they prescribe or recommend for use in the family is
not only bought on original prescription, it continues to
be used. All the consumer advertising published will not
divert Mrs. Brown or Mrs. Smith from continuing to use the
tonic, cough syrup or brand of vitamins that has been
recommended by the family physician. If Dr. Jones suggests
the use of a certain brand of baby food, strained soup or
cereal. Junior stays on that brand despite the pleading of
the radio commentator or the four color art work appeals in
national consumer magazines. The soap the dermatologist
recommends for his sensitive skin is the one that Mr. White
continues to use. The analgesic, oral antiseptic or vitamin
product that the dentist prescribes will have patient
preference because of its professional endorsement.
All available evidence points to the fact that
promotion directed to the medical and allied professions
is quite likely to produce stability in the demand for
trade-branded products. If you can sell the individual's
physician on the value of your product, your chances are
good of keeping the individual sold on It.
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Sales and advertising promotion to the profession-
al group engaged in the healing arts, if properly directed,
promises substantial and profitable returns. It must be un-
derstood, however, that methods which may be successful in
producing a favorable response from the general public are
pretty certain to fail if they are employed in a campaign to
professional groups. Because physicians have alert minds
and are trained in diagnosis, they will analyze your sales
and advertising message more critically than the average
reader. If they find in it overstatement or exaggeration,
they will not give your product consideration. The promo-
tion methods that will successfully influence the physician
to prescribe or recommend your product have been so clearly
established that that need for experimentation is eliminated.
The promotion program is divided into three essential parts
-- journal advertising, direct mail, and personal calls made
by detail men. While there are some reports that good re-
sults have been obtained when only one or two of these
methods have been employed, the evidence is conclusive that
permanence in demand is more apt to follow the use of all
three
.
If your product is one which is acceptable to the
advertising committee of the American Medical Association,
space in the Journal of the American Medical Association
should be employed. In addition to this official journal,
complete general coverage can be obtained by using Modern
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Medicine, Medical Economics or Current Medical Digest. These
are sent free to physicians. Modern Medicine and Current
Medical Digest, devoted to abstracts or digests of recent
medical literature have a great reader interest. Medical
Economics, because it presents well written articles on eco-
nomic problems of the physician, also has a great reader
interest
.
The use of direct mail in advertising pharmaceutical
products is common and effective. To carry out a successful
direct mail program there are certain fundamental principles
which must be recognized. Most important are:
1. Frequency of mailing: To be effective direct
mail must be regular and frequent. It should
be appreciated that the printed salesman has
to work much harder for attention and interest
than the personal visit from a detail man.
2. Presentation: Physicians give little atten-
tion to ill-prepared, poorly presented direct
advertising. The secret for success seems to
be to tell your new product story crisply and
with illustrations — if they lend themselves.
Easy to read typography, white space and at-
tractive design are important points to
consider
.
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While most of the direct mail budget is understand-
ably spent in promoting the physician there is something to
be said for including the drug trade, too. Experience has
shown that an announcement should be made to the drug trade
describing the new product, the suggested retail price, and
the promotion planned to create physician acceptance. From
time to time further mailings of interest might be sent as
"follow-ups" to sustain interest.
All physicians in the country have a right to ex-
pect that the representatives of manufacturers be carefully
trained both as to product information and detailing tech-
niques. Pharmaceutical representatives should make their
presentations brief with due regard for the physician's time.
These representatives should have a clear understanding of
the indications for the products as well as the contra-
indications. When they do not know the answer to a question,
they should make a frank statement to this effect and secure
the information from the Medical Department of the Company.
The manufacturer should not select from general literature
that which suits his purpose and ignore that which does not.
This is true particularly of a medical and scientific paper
which includes both favorable and unfavorable statements re-
lating to therapy with his products
.
The information which is given to the physician by
the detail man should be informative, but should not be
presented in a manner which is pedantic. If all observe the
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rules of courtesy, good taste and good practice in making
presentations, physicians everywhere will be more inclined
to set aside time for the detail man.
The retail pharmacists have a right to expect that
the new specialties they buy are really detailed to the phy-
sicians in the areas where they are stocked and that pre-
scription demand is created. Every retail pharmacist has
considerable money invested in specialties which are not
moving; some of which have become obsolete. Many of the
packages have been opened and thus are not usually return-
able for credit.
It can be argued convincingly that prescription
profits on rapidly moving specialties easily offset such
losses but it is the obligation of the manufacturers of
pharmaceutical products to hold such losses to an absolute
minimum. The pharmacist deserves the best cooperation in
bringing this about. The manufacturers can help in the
following ways:
1. Suggesting minimum initial purchases
2. Watching stock for turn-over
3. Transferring stocks when necessary
4. Most important of all: Maintain the
promotion program relentlessly ... if
a product is worth placing on the market,
it is usually worth promoting.
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Pharmacists also have a right to expect that they
be given full information regarding new products, either by
mail, trade journal or personal visits by representatives.
This statement may sound platitudinous but the facts are
that pharmacists all too frequently first hear about a new
product from the doctor who writes the prescription or
orders the product for office use.
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Appendix A
Material from the PHARMACEUTICAL
EXECUTIVES YEARBOOK-1947, published
by Romaine Pierson Publishers, Inc.
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Present Status of Drug Labeling
Under amended regulations of the Federal Food,
Drug and Cosmetic Act, effective October 10, 1944:
A drug is misbranded unless its labeling bears
adequate directions for use. "Labeling” is defined to mean
either the label attached to the package or a printed cir-
cular accompanying it. ¥here the size of the actual label
does not permit the inclusion of adequate directions, they
may be given on a printed circular that accompanies the
package
.
Drugs intended for administration by iontophoresis
or parenterally must carry adequate directions. There are
no exceptions. As drugs in this classification are used by
physicians, dentists or veterinarians rather than by the
public, the directions should explain clearly the scienti-
fic use, indications and contraindications.
Exemptions from Adequate-direction Provisions
The Federal Security Administrator may issue regu-
lations exempting drugs from the adequate-direction provi-
sions if they are not deemed necessary for the protection of
public health.
Drugs restricted to sale on prescription only
(with the exception of those used by iontophoresis or
parenterally) must not carry directions. No representa-
tion about how or for what it is to be used shall appear
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on the labeling. However, all drugs restricted to sale on
prescription must state the quantity or proportion of each
active ingredient on its label. Complete information on
the use of such drugs shall be available to physicians
separately.
Drugs used as inactive ingredients, such as a
coloring, emulsifier, flavoring, lubricant, preservative,
solvent or excipient, are exempt from the adequate -direc-
tion requirements.
Drugs used in the manufacture of other drugs are
exempt if the label states "For Manufacturing Use Only.”
Caution : It should be noted that drugs intended
for use as ingredients of prescriptions cannot be
classified as "For Manufacturing Use Only.” They
are not exempt from the adequate-direction requirements.
Official drugs delivered for use by a physician,
dentist or veterinarian are exempt. They must not carry
directions for use but shall carry on their labels the
phrase: "Caution: To be dispensed only on the prescrip-
tion of a physician, dentist or veterinarian." This exemp-
tion does not apply to nonofficial drugs nor to official
drugs that are supplied in forms not intended for compound-
ing with other substances.
Recent Opinions
Based upon a study of the literature and informa-
tion obtained from endocrinologists, the Food and Drug
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Administration states that, because estrone, estradio,
estradiol esters and natural mixed estrogens have been shown
to be appreciably less potent when administered orally than
when the same amount, expressed in units or by weight, is
administered parenterally
,
labels on preparations for oral
administration should bear a forthright statement,
conspicuously displayed, to this effect.
The Administration also holds that unless vitamins
are present in significant amounts, they should not be
listed on the label. They may be carried on the label if a
qualifying statement, to the effect that the amount present
has no significance in nutrition, also appears.
These recent opinions may necessitate changes in
many labels now in use.
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Condensed Thoughts on the
Robins on-Patraan Act
The Robins on-Patraan Act specifically prohibits dis-
crimination in price between purchasers of commodities of
like grade and quality, where the effect of such discrimina-
tion may be substantially to lessen competition or tend to
create a monopoly.
The payment of commissions, brokerage or other com-
pensation, except for services rendered in connection with
sale or purchase, is prohibited.
Reduction in price for the purpose of destroying or
eliminating competition is forbidden.
Reduction in price made in good faith to meet an
equally low price of a competitor, or the services or
facilities furnished by a competitor, may be justified.
Selection of customers is permitted, provided such
selection does not result in restraint of trade.
Granting of a discount for quantity purchases is
permissible if the discount can be justified by a saving
in cost of manufacture, sale or delivery. Discounts for
quantity purchases must be available to all customers. If
the quantity in order to obtain a discount is set so high
th*at only a few dealers can take advantage of it, the
Federal Trade Commission may order its revision.
Merchandise deals are permitted if they are made
available to all customers on proportionately equal terras.
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Advertising allowances may be made if they are
available to all customers on proportionately equal terms.
Price changes are permitted to dispose of perish-
able, obsolescent or seasonable goods. Distress sales under
court process, or sales in good faith in discontinuance of
business in the goods concerned are also permitted.
.
Condensed Thoughts on the
Wheeler-Lea Act
The Wheeler-Lea Act specifically prohibits the dis-
semination of false advertisements by any means for the pur-
pose of influencing the purchase of food, drugs, devices or
cosmetics
.
"No advertisement of a drug shall be deemed
to be false if it is disseminated only to
members of the medical profession, contains no
false representation of material fact, and in-
cludes, or is accompanied in each instance by
a truthful disclosure of, the formula showing
quantitatively each ingredient of such drug."
As all unfair methods of competition are banned by
this act, any statement made in an advertisement that can be
interpreted as being derogatory to a competitor may be con-
sidered a violation.
..
.
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Material from the book,
DEVELOPMENT AND MARKETING
OF
PHARMACEUTICAL SPECIALTIES
by
William T. Doyle and A.R. Savina
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Chapter One
Research And Its Importance
Research constitutes one of the most important aids
in the development of ethical pharmaceutical specialties. In
its broadest sense the term ‘'research 1 ' refers to a method for
systematically accumulating, correlating, and applying new
knowledge. Since the research technique has been most widely
applied in the fields of science, it is commonly believed
that research is the creation of science and is limited in
its applicability to such fields . Science has in fact "gone
to town" with research and has demonstrated its possibilities.
Accordingly, industrial research departments are generally
organized chiefly for the purpose of carrying on scientific
and technical research. However, it is well known that prac-
tically all phases of a business can be aided by data gained
from analyses and studies conducted in accordance with re-
search methods. Factual and interpretative surveys are fre-
quently employed by enlightened management as a guide in
reaching decisions on matters of broad policy. Fields offer-
ing good sales potentialities for new products are disclosed
by market research studies. Methods for improving the per-
formance of salesmen are often uncovered by sales research.
The growing use of aptitude tests in the selection
of personnel emphasizes another important application of the
research technique. Production and control, commonly re-
garded as routine functions, rely upon research to insure
,
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replacement of obsolete equipment and manufacturing proc-
esses, and maintenance of product quality on the highest
possible level. The variety of research activities is
thus apparent
.
Evidence to prove the need for research would seem
superfluous indeed today. Pew still question that research
is a paying investment. The pharmaceutical industry as well
as others long ago recognized its importance in developing
new products and improving the quality of and widening the
field of applicability of existing products. Without the
stimulus of new and improved products, sales the lifeblood
of industry would rapidly dwindle. The past thirty-five
years have seen the number of industrial research labora-
tories in this country increase from a few to more than
3
,
000 .
Research not only benefits the companies which en-
gage in it, but it also contributes to the welfare of the
nation. This has been forcefully demonstrated by the
dramatic termination of the War.
Now with reconversion and its biggest problem, un-
employment, facing the nation research will stand out as the
one national resource of unlimited potentialities to aid in
establishing and maintaining prosperity on a high level.
How Much To Spend For Research .
A few years ago. Dr. Karl T. Compton, president of
the Massachusetts Institute of Technology, urged all U. S.
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companies to 3pend 2$ of their gross income for research. At
that time such a plan would have meant an annual expenditure
by all industry of one billion dollars for product develop-
ment and improvement about five times as much as was ac-
tually being spent. Without doubt, many companies have been
and will continue to spend more than 2% of their gross income
for this purpose, but it is evident that many spend much less.
The amount of income to allocate for research will naturally
vary with companies. Generally the smaller the company, the
greater the proportion of its income which may be required for
research activities. In many cases, however, research expendi-
tures may appear high because much that is essentially control
work is classed as research. An adequate research outlay for
pharmaceutical manufactures has been variously estimated at
from 2 to 10$ of gross income. It is up to top management in
each case to determine the most it can afford to spend to
maintain its competitive position and ultimately expand its
business. The amount decided upon will in all probability be
none too much.
Organization Of The Research Department
Size: Obviously the size of a research department
will vary with the size of the company and with the proportion
of income which can be allocated to research.
Personnel: The selection of personnel for a research
department requires very careful consideration. Management's
chief responsibility is in the selection of the director, who
F.r r "t
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then should be allowed a reasonable degree of freedom in pick-
ing those to work under him. The director of research should
have a broad training in those sciences chemistry, biology
and medicine which bear most directly on the industry. He
should possess a sense of economic values and be generally
well acquainted with what is going on in the field in which
the company is interested. While scientific and technical
knowledge is an important requirement of the executive in charge
of research, perhaps more important is his ability to handle
men. On this depends in large measure the efficiency with
which a research laboratory operates.
In most instances new products result from group
rather than individual efforts. Accordingly, teamwork amongst
the members of a research department is essential for success.
Effective teamwork will depend on the enthusiasm with which
the men pull together for the development and improvement of
all under the leadership of the research director. Hence he
must inspire confidence and loyalty, be the nucleus around
which develops that subtle quality characterizing winning
teams an "esprit de corps". In addition he should contact
people easily, and should make it a practice to discuss prob-
lems periodically with others both within and without the
organization, for such discussions are often a fertile source
of ideas. Also he must be a salesman, capable of getting
management's approval for necessary or worthwhile research
expenditures. This is a large order indeed, but the closer
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the man selected meets these requirements, the greater the
assurance of success in the research program undertaken by
the company.
Perhaps the two most important requisites for
staff members of a research department are good fundamental
training and adaptability. For large organizations special-
ization in some branch of science may be necessary, but for
small and medium-sized companies this is not essential and
probably undesirable.
As research departments grow, subdivision becomes
necessary. There may be sections or divisions devoted to
studies in a special field and these may be further divided
into groups. Each of these subdivisions should be headed by
a leader, the group leaders being responsible to the sec-
tion or division heads, who in turn are responsible to the
research director.
The active head of research whether he be the re-
search director or executive in charge of research and de-
velopment should be a member of the management committee or
an officer of the company so that research will be assured
of forceful representation.
The handling of personnel deserves the most careful
attention of management. Financial compensation must be
adequate. Incentive plans should be instituted to reward
good work, but in the execution of such plans care should be
taken to avoid penalizing a worker whose assignment while not
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fruitful was nevertheless well carried out. When the size
of the department permits, all members should probably share
in the rewards so as to foster the spirit of teamwork. The
desire to grow and develop should be recognized by manage-
ment as a natural characteristic of most research men, and
there should be opportunities for this within the company if
interest is to be sustained.
Some individuals will grow and develop in spite of
all the obstacles management may place in front of them.
Others may have to be helped. It would seem to be the part
of good judgment for management to provide such assistance
and encouragement when necessary or desirable. The enthu-
siasm and consequently the productivity of research personnel
can be improved when it is evident that a spirit of helpful-
ness pervades the organization from top management right on
down to the individual worker. All will feel that they are
part of the team and act accordingly.
Facilities: Needless to say adequate facilities
should be provided for the proper conduct of research. With-
out the necessary tools, personnel cannot function efficiently.
The laboratory should be large enough, clean, orderly, well-
lighted, and located away from excessive noise. It. should be
adequately equipped with modern apparatus. A library with
the more important chemical, pharmaceutical, and medical
journals is as essential as all other facilities. Experience
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has shown that those companies with the most progressive re-
search facilities generally make the greatest strides.
Objectives Of Research Department
Once a properly staffed and equipped research
laboratory has been set up its objectives and the scope of
its activities should be sharply defined. The general ob-
jectives usually comprise the following:
(1) Develop new products. Very few products, phar-
maceutical specialties as well as other types, can be ex-
pected to retain their market position indefinitely unchanged.
Eence a continuous search must be carried on for new products
to replace the old before they are displaced by competitors'
products
.
(2) Improve existing products. Oftentimes a
product can be re-created and its life prolonged by an im-
provement .
(3) Seek new applications for the company's products.
Even with medicinal products the field of application can fre-
quently be widened.
(4) Develop new and improved methods of production
and control. Obsolete manufacturing processes and inadequate
control of quality can seriously jeopardize the success of a
product by giving the more efficient competitor a definite
advantage
.
(5) Furnish technical information and assistance to
other departments of the company. The production and sales
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departments particularly can benefit by frequent and regular
contact with the research department.
(6) Conduct fundamental investigations to contrib-
ute to the accumulation of "scientific capital", the basic
source of new products.
(7) Publish papers. Research workers frequently
desire the opportunity to publish the results of their work
in scientific journals to help establish a name and reputa-
tion for themselves in their field. The company will also
benefit by a liberal policy in this respect for its prestige
will be enhanced. Obviously the work must be of such a type
and carried out in such a manner a3 to be worthy of publica-
tion.
..
Chapter Two
New Product Development
Perhaps the most important single objective of the
research department, at least for manufacturers of ethical
pharmaceutical specialties, is to develop new products.
"What's new?" is the question most detail men are confronted
with when they step into a doctor's office, and the detail
man looks to his company's research department for the answer,
the research department with the cooperation of management,
sales and production must constantly and vigorously pursue a
systematic course directed toward this objective. Too often,
particularly in the smaller companies, so much of the depart-
ment's time is diverted to problems unrelated to the develop-
ment of new products, that this more important task is handled
in a hit-and-miss fashion. Success then becomes largely a
matter of luck a weak foundation on which to build one of
the most vital departments of a company. New product develop-
ment can be placed and maintained on a sounder basis by ap-
proaching it as all major problems are approached. First a
careful and thorough analysis of the problem is made, then it
is separated into its component parts, and these are then
arranged in their proper sequence for systematic attention.
In the paragraphs which follow an attempt is made
to outline a series of steps that may be taken in a methodi-
cal attack on the all important problem of new product de-
velopment. Obviously, no hard and fast rules can be laid
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down for the conduct of research in all cases, but the prin-
ciples underlying the procedure outlined should find general
application although the steps themselves may vary.
Directions In Which New Product Development May Proceed
A classification of the possibilities is always a
helpful way to begin a project. A clearer understanding is
thereby gained of the problem, and this is half the solution
New products may result from studies to:
(1) Synthesize new chemicals for medicinal use.
(2) Investigate existing compounds and natural
products for their possible therapeutic value.
(3) Isolate or concentrate agents of therapeutic
value from natural products.
(4) Develop new and unique preparations compris-
ing substances of established worth in medicine, such prepa-
rations supplying active raedicinals in a vehicle or form to
improve their efficacy, consumer acceptance and safety.
Which of the above-listed courses are followed
will depend upon the size of the company and its research de
partment, and also on management's decision regarding the
latitude of its activities. Large companies will generally
work simultaneously in all directions, the smaller companies
in probably one or two.
Origin Of Ideas For New Products
Unfortunately too little attention is given to
t
means of acquiring ideas for new products. Chief reliance
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appears to be placed upon inspiration rather than on the
adoption of a procedure to stimulate ideas. It should be
remembered that inspiration usually enters a prepared mind;
what is frequently termed inspiration is merely the final
step in a sequence of logical steps directed toward a
definite goal.
The ideas for new pharmaceutical products may come
from different sources, some of which will be discussed.
Sometimes bits of information from various sources when put
together lead to the formulation of an idea. Therefore,
every effort should be made to cultivate close contacts be-
tween the departments with a company so as to encourage the
development of ideas. Ideas, or pertinent information lead-
ing to them, may come from:
(l) Management. The origin of many companies can
be traced to an idea possessed by the founder or founders,
and accordingly the company's first management. As companies
grow and become more highly organized, management's numerous
functions preclude its being the only or even an important
source of ideas for new products. However, management's
policies can have a profound effect on the inception and de-
velopment of ideas by others within the organization.
Management's chief role should be to furnish and
maintain a favorable environment for the germination and cul-
tivation of ideas. Fields of interest to the company should
be carefully delineated, but they should not be too narrow.
Chief reliance should be placed on a planned and systematic
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procedure for conceiving new product possibilities rather than
on individual bursts of inspiration. Adequate means should be
provided for a full examination and evaluation of ideas, and
rewards and recognition for worthwhile ideas should be an in-
tegral part of company policy.
(2) Research Department: A well-organized research
department in a company with a research-minded and progressive
management will in the long run prove to be a fertile source
of ideas for new products and product improvement. For
optimum effectiveness the research department should adopt and
adhere to an orderly and systematic plan especially designed
to indicate new product possibilities worthy of consideration.
Among the steps that such a procedure might embrace are:
(a) Follow up disease and therapeutic trends with
the aid of medical literature, insurance com-
pany statistics and government health reports.
(b) Maintain an up-to-date file of information on
the status of the treatment of important dis-
eases, or symptoms for which medicinal therapy
is indicated.
(c) With the aid of periodic surveys follow up
market trends in the pharmaceutical field.
(d) Study drugs and drug products in current use
with a view to determining their shortcomings
and how these might be overcome.
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(e) Maintain contacts with practicing physicians,
clinicians, hospital and university investi-
gators, and pharmacists as a means of keeping
abreast of advances in therapy and of the re-
quirements in medicine. This may be accom-
plished in part by permitting research depart-
ment members to attend medical and scientific
meetings, and also, if possible, to take
periodic refresher courses.
(f) Encourage frequent informal discussions on
new product possibilities. Many points that
would not be disclosed in formal conferences
might be brought up in an informal group
gathering. Out of these discussions may
crystallize ideas suitable for presentation
and evaluation at formal conferences.
(g) At regular and frequent intervals circulate
bulletins to executives and research workers
with pertinent information on new fields of
interest to the company. If prepared with
care and thought these bulletins may help to
stimulate thinking in profitable channels.
Discussions that raise questions should be
part of such bulletins, and may well pave
the way for formal consideration of new
product ideas
.
..
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(3) Sales Department: Coming into contact regu-
larly with druggists and doctors, who being close to the
point of application are in perhaps the best position to ob-
serve the failings of, or the gaps unfilled by available
products, salesmen might be expected to be a good source of
ideas for new products. In some instances ideas of consider-
able merit do originate in the sales department, particularly
among the men whose primary function is detailing or special
service rather than selling. By and large, however, new
product suggestions from the sales department are generally
requests for a product like a fast selling competitive item.
Nevertheless, salesmen can be instrumental in furnishing much
useful information to aid the research and other departments
to develop and evaluate new product suggestions. Being close
to the market, they can learn much about trends in therapy,
fields showing good sales possibilities, and limitations of
existing products --information that should prove advantageous
to the research department, and to those groups within the
company charged with the responsibility of new product
development
.
Sales management should make it a policy to en-
courage salesmen to send in information of this character
regularly. More than a simple request should be made if
worthwhile results are to be expected. Careful thought
should be given to the means of enabling the men to furnish
the desired information with a minimum expenditure of time.
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The value of the data collected in this manner will generally
be in direct proportion to the time and thought put into
preparation of the forms or questionnaires on which the sales-
men are to make their reports.
As a further incentive, periodic reports should be
made to the salesmen showing what use or disposition has been
made of the information sent in. Evidence of interest at the
home office will stimulate interest in the men.
(4) Others. Ideas may come from other sources al-
though these are of minor nature in the sense that a company
would not want to make them the sole basis for its future
progress. But since on occasion, ideas of considerable merit
may come from these sources, they obviously should not be
overlooked
.
/
Physicians from their experience in the diagnosis
and treatment of disease may have ideas which they would like
to have a pharmaceutical company with the necessary facili-
ties work out and ^apply. Naturally, not every idea from such
a source can be expected to lead to a profitable new product.
Like all other ideas these must be evaluated in the customary
manner
.
Other companies not engaged in the manufacture of
pharmaceutical specialties, or not affiliated with such a
company, may develop products of possible value in the phar-
maceutical field. The progressive pharmaceutical manufac-
turer will find it to his advantage to cultivate contacts
with such companies.
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Many individuals working independently frequently
approach companies with partially worked out ideas which they
offer for sale. Needless to say, caution must be exercised
in evaluating such proposals before any commitments are made.
The employees within a company should not be
neglected as a source of ideas. With a little encouragement
some with the proper background may yield worthwhile sugges-
tions .
Screening Ideas
Next in importance to acquiring ideas is their
evaluation, to classify them according to whether or not they
deserve further study and if so, how much. All ideas should
be carefully scrutinized before large sums of money are ex-
^ pended on their development, but this does not imply the
adoption of a "hardboiled” attitude toward new product ideas.
On the contrary, an objective study should be made of each
idea with all factors of importance receiving consideration.
Most companies will have a group, often designated
as the New Products Committee, entrusted with the responsi-
bility of screening new product ideas and making recommenda-
tions regarding their disposition. This committee should be
composed of at least a representative of top management, the
research director and the sales, advertising and production
managers. Legal and clinical representation are also very
desirable, but where the size of the company does not permit
this a patent attorney and one or more physicians qualified
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to present the clinical point of view should be retained on a
consulting basis. They may attend meetings with the New
Product Committee particularly after ideas have been carried
part way along the screening process. Among the factors which
should receive attention by the New Products Committee in its
evaluation of new product ideas are the following:
(1) Sales Factors: Typical questions that logically
arise in a discussion of sales factors are:
(a) What are the sales possibilities of the sug-
gested product? Does the product contribute
something new?
(b) Is the market worth cultivating?
(c) Will an educational campaign be necessary to
insure ready acceptance of the product? How
much will such a campaign cost?
(d) What sort of competition is the product likely
to encounter immediately upon its introduc-
tion or later?
(e) Will sales fluctuate with the seasons?
(f) What will the price picture be?
(2) Research Factors: Here, too, typical questions
help to indicate the points around which discus-
sion might revolve in determining, from a re-
search standpoint, whether an idea merits
further investigation:
..
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(a) What are the probable difficulties that re-
search may have to overcome?
(b) About how much time will be necessary to
complete the laboratory phases of the study?
(c) Are personnel with the proper qualifica-
tions available for carrying on whatever
research the product may require?
(d) What is the best estimate that can be given
of the probable cost for carrying out the
research program?
Orienting experiments may be necessary
before answers of any value at all can be
given to the questions just raised. Even
the answers can not be accepted as final
because the problems of research cannot
always be foreseen.
(3) Production Factors: The manufacturing problems
likely to arise should be given consideration
early in the screening process for unless the
facilities in plant, equipment, and personnel
are available or procurable, research on the
project may be largely wasted.
The probable cost of production should be
taken into account too, for if costs are ex-
cessively high serious marketing problems may
be encountered. However, it should be borne
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in mind that before research on a product is
completed and a manufacturing process worked
out, production cost estimates may be out of
line
.
(4) Clinical Factors: Obviously no pharmaceutical
specialty should appear on the market without
previous clinical evaluation. Hence the na-
ture of any clinical studies that may be re-
quired should receive attention. Apart from
this, however, the clinican point of view is
desired during the screening process in order
to help in reaching a conclusion as to whether
the proposed new product will fill a real
clinical need.. The clinical viewpoint will
also be found helpful in outlining the general
characteristics the product should posess to
fit its purpose best.
(5) Legal Factors: Before work is initiated on any
new project the patent situation should be
thoroughly explored. Preliminary surveys may
be sufficient during the screening process to
indicate whether existing patents will have to
be circumvented and whether this is likely to
complicate the research picture.
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Preparation is the keynote of success in any com-
mittee deliberations. Offhand opinions based merely on
superficial impressions are practically worthless as evidence
to judge whether an idea for a new product merits adoption.
The chairman of the New Products Committee should not only
inform committee members beforehand regarding the subjects to
be discussed but should assign certain members topics which
they are well qualified to comment on in detail.
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Chapter Three
Research Procedure
When the New Products Committee
,
or its equivalent,
has recommended that research be conducted in a certain di-
rection with the ultimate objective of developing a new prod-
uct, and management has authorized an expenditure for the
purpose, the research department then carries on from that
point. It has often been said that research cannot be made
to fit into any fixed pattern. Too many encumbrances can
certainly stifle originality and progress in any research
project. This, however, does not preclude the need for some
measure of organization in the conduct of a research program.
Research in industry has been shown to yield its biggest re-
turns when carried on within a framework designed with due
regard to certain basic principles of organization. In this
connection we are concerned with organization of research
procedure as distinguished from the research plant.
One of the first policies to be established is the
fraction of effort which should be devoted to this or that
type of research. Various terms have been used from time to
time to describe types of research pure, applied, practical,
fundamental, and so on.
The development of new pharmaceutical specialties is
without question applied research, dependent upon fundamental
research conducted either within or without the company. In-
dustry obviously is most interested in supporting applied
'.
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research, but it would indeed be shortsighted to fail to
carry out, or support, the fundamental research from which
profitable ' applications are drawn.
The problems undertaken by the research department
should include both short and long range types, with the
time devoted to each about equally divided. In this way new
products can be made available at regular intervals to aid
in the support of long term investigations. At times research
on short range problems is spoken of as empirical, and that on
long range problems systematic or fundamental. Such a classi-
fication or distinction may be misleading, for so-called
"empirical research" to be successful should be systematically
and orderly executed. The emphasis is on achieving a limited
objective in as short a time as possible. The degree of
success in this type of research depends to a large extent
upon the knowledge and experience built up over a period of
time by previous work on both long and short range problems.
Continuous systematic study develops the ability to perceive
quick solutions to a problem and to sense possible new prod-
ucts requiring only limited research.
What is frequently believed to be a "hunch" is a
normal response to stimuli aroused by the pursuance of a ba-
sically sound research course. Too much reliance on em-
piricism is dangerous, for success by this method of approach
is sporadic. A research method dependent chiefly upon lucky
guessing could hardly be considered well suited to the needs
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of modern industry. It is true that some of today's impor-
tant medicinal agents were developed or discovered in an
empirical fashion, in some instances by persons lacking in
scientific knowledge and background. Pew, however, would
advocate that the same empiricism characterizing ancient
folklore should dominate today's attack on disease.
Long range problems may require two or more years
for completion. They may involve fundamental investigations
with no immediate prospect of any return in the form of a
new product. Yet out of such investigations often come the
major development which establish a company's position in its
field. To be identified with such a major development is a
valuable asset.
Apart from the reasons just given for including
both long and short-range problems in the research program,
it is also desirable that several projects be underway at any
one time because the element of chance cannot be fully
eliminated from research.
As it is not known in advance where lightning will
strike, it is not possible to foretell which research pro-
jects will lead to profitable new products.
Irrespective of the type of problems included in the
research program, the general procedures followed in the solu-
tion of these problems will be essentially the same, consist-
ing of the following steps:
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(l) Survey of the Literature : Too much emphasis
cannot be placed on the importance of under-
taking a search of the literature medical,
scientific and patent prior to initiating
an extensive experimental program. Much money
and time can be saved by avoiding repetition
of work that has already been done. Moreover,
a good literature search enables the research
worker to become better acquainted with the
field. This background of information will be
an indispensable aid in planning and carrying
out the experimental program, and in formulat-
ing ideas for patenting. Obviously a good
library should form part of the research or-
ganization. As mentioned earlier, the library
is an important research tool and every effort
should be made to enlarge its usefulness by
increasing the number of scientific journals
in its files, by purchasing new books of in-
terest, and by providing personnel to aid in
the preparation of bibliographies and abstracts.
When the laboratory is located close to large
cities with good medical and scientific
libraries, it will be advantageous to make ar-
rangements for the use of facilities.
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In order to derive the maximum possible value
from literature searches and at the same time to
have the information gathered readily available for
future reference, it is desirable to prepare and
maintain card files which are properly indexed with
respect to both subjects and authors. A single
file may be assigned to each particular field under
investigation. The form of card and the system em-
ployed in filing may be arranged to meet the needs
of the particular laboratory.
The card file should be supplemented by ab-
stracts or condensates of articles having a direct
bearing on the research in progress. Condensates
may comprise an analysis of the information pre-
sented in a paper from different points of view, the
purpose being to enable the research worker to get
a clear comprehension of the relationship of the
author's work to his own proposed study.
Organization of the information gained from the
literature survey for a particular field into a
single connected review will prove very useful not
only while the research work is under way, but also
after it has been completed.
Perseverance and thoroughness are necessary to
maintain a well-organized, informative, and up-to-
date file of the literature in any field. Effort
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expended in this direction, however, is usually-
reflected in a better quality of research. It
must be stressed that literature study is actu-
ally a means to this end, not an end in itself.
(2) Planning Experimental Program : Good research
work requires a considerable amount of careful
planning at the outset. The more time spent in
planning the less will be wasted in costly ex-
periments that fail to yield conclusive data.
A frequent error on the part of management is to
bring pressure on research for immediate results,
thus causing experimental work on a broad scale
to be started prematurely. It is not intended to
infer that no experiments should be started until
a comprehensive plan has been outlined or the
literature survey completed. On the contrary, it
may be highly desirable to conduct preliminary
orienting experiments while both these first two
steps are in progress, for the results of such
experiments may facilitate subsequent planning.
(3) Carrying out Experimental Program : There is
probably no good substitute for the inspiration
and perspiration formula. Every possible variable
must be considered and, if necessary, investi-
gated. No deviation from the systematic course
outlined should be made unless clearly warranted
by the results being obtained.
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Assistants should be employed to take care
of the more routine function of the experimental
program, thus freeing highly trained personnel
to devote more time to study and correlation of
data, and the planning of future experiment.
(4) Clinical Evaluation : It is hardly conceivable
that any reputable company would introduce a
pharmaceutical product on the market without
previous clinical evaluation. The extent of
the clinical evaluation will of course be de-
pendent upon whether the product contains an
entirely new drug or whether it contains a
drug known therapeutic action in a new form.
In the case of new drugs pharmacological
studies niay have to precede clinical studies.
Large companies will generally have the facili-
ties for carrying out the former; small com-
panies may have to have such work conducted by
outside laboratories. Clinical studies will
invariably be carried out at a hospital under
the direction of a qualified clinician. Com-
panies should establish contacts with several
hospitals to faciliate the handling of clinical
evaluation studies. If possible a physician
should be employed full time to take charge of
this phase of the work. If desirable patient
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acceptance tests can generally be conducted
simultaneously with the clinical evaluation
studies
.
(5) Pilot Plant Studies : Large scale manufacture
of a new product should seldom be undertaken
without trials first on a small scale, larger
however than laboratory scale. The purpose of
this is to determine whether problems are like-
ly to be encountered in commercial production
that were not apparent in the laboratory.
Variables in the manufacturing process can
sometimes be studied better on a pilot plant
scale than on a laboratory scale, but where this
does not hold true the studies should be carried
out in the laboratory to keep costs at a minimum.
For small companies the pilot plant may form
part of the research department, but in large
companies it may be better to have the pilot plant
as a separate unit. Obviously, in such cases a
close liaison between the research department and
the pilot plant should be maintained. When a
product is produced on a pilot plant scale it is
usually possible to get a more accurate estimate
of the cost of manufacture.
Clinical evaluation tests may await the
pilot plant trials when a larger quantity of the
product can be made available for distribution.
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Research Conferences
Research work can be frequently expedited by hold-
ing periodic meetings at which mutual problems are discussed.
When the research staff is small all members may profit by
attendance at such meetings. With large companies on the
other hand the presence of all research workers would make
the meetings unwieldy. Greater effectiveness would be as-
sured by restricting the meetings to small groups working in
related fields. However, the leaders of all groups should
meet regularly with the research director to discuss the work
in progress. Group leaders may in turn pass on to their
groups the information obtained at these general meetings.
Keeping all members of the staff informed regarding the work
going on in other parts of the laboratory, especially when it
is a large one, is an important factor in the promotion of
harmony
.
The frequency with which meetings are held is a
matter that must be decided for each individual case. Once a
week would seem to fit the majority of cases. Those attend-
ing the meetings should come prepared to participate in the
discussions. One individual may be appointed as secretary
with the responsibility to prepare a report of each meeting.
Research Reports
It goes without question that periodic progress re-
ports of the work carried on in the research department should
be submitted to management. The manner of reporting will
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doubtless vary with the size of the company. Each research
worker should submit a progress report of his own work to
his group leader or to the research director at intervals
of perhaps once a month. From these the research director
may prepare monthly reports for management. When a problem
or some specific phase of it is completed, a detailed report
may be prepared by the worker showing what was done and the
results obtained. These reports may be circulated among
members of the research department and also among the execu-
tives of the company. These will form a record of the work
completed and may be filed so that they are available for
future reference.
Budget
A budget is a necessary means for maintaining a
check on research costs. When an appropriation is made
authorizing research on a specific project, an identifica-
tion number should also be assigned to the project. The
time of personnel and expenditures for materials and
equipment may then be charged against the project number,
and periodically the accounting department may issue state-
ments showing the accumulated cost and the residual appro-
priation. At intervals of possibly six months the expendi-
tures on a research project and the progress made should be
reviewed with the object of determining whether research
should be continued or brought to a conclusion. This may
well be a function of the New Products Committee. At such
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meetings all executives from top management down must strive
to be as objective as possible in the exercise of their
j udgment
.
A research budget should be so arranged that it does
not restrain research activities and does not consume too much
of the time of personnel in its operation. The amounts allo-
cated for specific projects should be regarded as flexible,
and upon exhaustion should not necessarily signify the termina-
tion of the project. Viewed in the proper light, a budget can
be helpful in keeping research expenditures in productive
channels thereby avoiding the squandering of funds on worth-
less projects.
Production And Control
After a product has been brought to the pilot plant
stage, it should be evident what the manufacturing and control
problems are likely to be. Steps may then be taken to pro-
vide the required facilities if they are not already available.
The research department and pilot plant unit should work in
close contact with the production department until all kinks in
the manufacturing process have been worked out.
It is hardly necessary to point out that great care
must be exercised in each step of the manufacturing process,
and control specifications must be rigidly adhered to if phar-
maceutical specialties are to reach the consumer in a safe and
effective form. With new products this need is even greater
since it is not easy to anticipate possible sources of diffi-
culty .
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Among the conditions to be met In the production of
pharmaceutical specialties are:
(1) The final product must conform with the label
specifications
.
(2) The product should have good shelf stability.
(3) The composition should not be altered in any
way during manufacture that might later on
produce untoward reactions.
(4) Sterility, when necessary, should be assured.
(5) Proper environmental conditions should be pro-
vided light, cleanliness, conditioned air,
and so on
.
(6) Packaging and finishing of the product should
conform to the highest standards.
The control department should be regarded as an ad-
junct to the manufacturing department, with the responsibility
of insuring the quality of the finished product. It should
therefore be segregated from the research department. Among
its duties may be the following:
(1) Test incoming materials and the finished pro-
duct to establish identity and strength.
(2) Insure correct formulation.
(3) Check manufacturing operations to avert con-
tamination of the product or loss of active
matter, and also to insure uniformity of the
product
.
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(4) Check filling, labeling, and finishing of the
product
.
(5) Make sure government regulations are observed
insofar as the package is concerned.
The more complex the product to be manufactured the
more alert and careful the control department must be. The
department should be staffed with adequately trained personnel
capable of developing and carrying out the necessary control
procedures to insure the manufacture of products of the high-
est quality obtainable.
Consultants
No company is completely self-sufficient insofar as
research is concerned. The great reservoir of fundamental
knowledge constantly being replenished by research conducted
in university and hospital laboratories, is a major source of
the information on which new product development is based.
In addition, the facilities of consulting organizations, hos-
pitals, universities and colleges are often needed to supple-
ment those of the company's own research department. Like
all departments and persons connected with new product de-
velopment great care should be exercised in selecting outside
consultation.
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